Are uterine leiomyoma a consequence of a chronically inflammatory immune system?

Ganesa Wegienka
In: Medical Hypotheses · 2012 · vol. 79(2) , pp. 226–231 · doi:10.1016/j.mehy.2012.04.046 · PMID:22608860 · W1987714323
article OA: closed CC0 ⤵ 9 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-07, 2026-07-18 ⓘ

This paper hypothesizes that uterine leiomyomas may be caused by a chronically inflammatory immune system dominated by T helper 17 cytokines, suggesting potential avenues for preventative treatments.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The cumulative incidence of uterine leiomyoma at age 50 is ≈ 70% in White women and >80% in Black women. Although risk factor research is limited, increasing age, and being premenopausal, nulliparous or Black are risk factors for leiomyomas. Black women tend to have larger leiomyomas and be younger at diagnosis. Surprisingly little is known about the etiology or pathogenesis of uterine leiomyomas. Women with diagnosed uterine leiomyomas have higher healthcare costs - more than 2.5 times that of women without a diagnosis. In the United States, leiomyomas are the leading indication for hysterectomy. The proposed hypothesis is that leiomyomas are caused in part by a systemic immune milieu that is chronically inflammatory - one that predominates in T helper 17 (Th17) cytokines. Inflammation can be problematic if it is not well regulated. Should an inflammatory imbalance be demonstrated to be associated with leiomyoma development and growth, this would provide an avenue for development of preventative treatments (e.g., focus on anti-inflammatory pathways), which would substantially reduce the morbidity costs of these tumors and reduce a known health disparity.

My notes (saved in your browser only)

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (95)

Cited by (9)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK